NEWBURYPORT, MA — (Marketwired) — 12/09/13 — PCI Synthesis, Inc. (), a 15-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs) and other specialty chemical products, today announced a list of trends it thinks will impact the emerging biotech and generic drug industries in 2014.The FDA continues to expand its scope for oversight — most recently with a bill signed into law in November, the Drug Quality and Security Act. There-s
